MitoSense, Inc. is proud to announce its participation in the 2024 Military Health System Research Symposium (MHSRS), taking place August 26th to 29th, 2024 in Kissimmee, Florida. MHSRS is the Department of Defense’s premier scientific conference focused on the unique medical needs of the American warfighter.
Traumatic brain injuries (TBI) pose a significant and common concern for military personnel and veterans. TBIs can often lead to significant and long-lasting neurological damage, driven by mitochondrial dysfunction.
MitoSense has been collaborating with the Walter Reed Army Institute of Research (WRAIR) and the Department of Veterans Affairs (VA), through the James A. Haley Veterans' Hospital, in developing prehospital therapeutic treatments for TBI utilizing MitoSense's patent-pending Mitochondrial Optimization Therapy (MOT™) technology. The research aims to recover mitochondrial function and enhance neuroprotection following TBI. This has the potential to improve health outcomes for service members affected by TBI, a topic of paramount importance at the MHSRS.
The research will be presented by Dr. Mark Kindy of the VA during Poster Session 1 on Tuesday, August 27, 2024 at poster 512.
Attendees of the MHSRS are encouraged to attend Dr. Kindy's poster session and also visit MitoSense at booth 213 to learn more about these groundbreaking advancements and to discuss potential collaborations.